|
Overview
The revolution in genomics and proteomics spawned by the human
genome project is providing a steady stream of protein therapeutic
candidates. Many of these proteins require enhancements in their
pharmacokinetic properties in order to be clinically effective
because of inherent limitations of proteins as drugs. Advanced
Proteome Therapeutics has initiated a program that is broadly
applicable to proteins. It builds on a technology platform developed
over twenty years of targeting proteins for site-selective modification
and addresses issues which limit therapeutic utilization of promising
proteins.
The Company’s laboratories are located at the BioSquare
Innovation and Discovery Center on the campus of the Boston University
School of Medicine. Its scientists are engaged in research and
development applying leading edge chemical and biochemical methodologies.
|
